U.S. RESEARCH ROUNDUP- Perficient, Target, Vertex Pharmaceuticals May 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Perficient, Target and Vertex Pharmaceuticals, on Tuesday. HIGHLIGHTS * Cerence Inc CRNC.O : Needham cuts to hold from buy * Gap Inc GPS.N : Citigroup raises to buy from neutral * Perficient Inc PRFT.O : Alliance Global Partners cuts to neutral from buy * Target Corp TGT.N : Citigroup raises to buy

Microchip Technology Inc reports results for the quarter ended in January - Earnings Summary Microchip Technology Inc MCHP.OQ reported quarterly adjusted earnings of 57 cents​​ per share for the quarter ended in January, lower than the same quarter last year, when the company reported EPS of $1.64. The mean expectation of twenty two analysts for the quarter was for earnings of 57 cents per share.

BUZZ-Microchip Technology falls after first-quarter outlook below estimates ** Shares of chipmaker Microchip Technology MCHP.O fall 4.4% to $89.61 in aftermarket trading ** Co forecasts Q1 revenue between $1.22 bln and $1.26 bln vs analysts' average estimate of $1.34 bln - LSEG data ** Expects Q1 adj EPS between 29 cents and 32 cents vs analysts' e

Microchip Technology expects weak quarterly results on excess inventory impact May 6 (Reuters) - Microchip Technology MCHP.O forecast first-quarter net sales and profit below Wall Street estimates on Monday, signaling weak demand as customers continue to clear excess inventory, sending its shares down more than 4% in aftermarket trading. Slowing electric vehicle sales at a time when customers are clearing excess inventory have weighed heavily on demand for chips in the automotive industry, hitti

BRIEF-Microchip Technology Q4 EPS USD 0.28 May 06 (Reuters) - Microchip Technology Q4 net income USD 154.7 million. Q4 operating income USD 253.5 million Q4 sales USD 1,326 million vs. IBES estimate USD 1,330 million